Healthcare
1068 companies in this sector
Insider Buys (30d)
128
$73.11M
Insider Sells (30d)
735
$2.05B
Monthly Insider Volume
Industries
Biotechnology604 companies
Medical - Devices131 companies
Drug Manufacturers - Specialty & Generic66 companies
Medical - Instruments & Supplies52 companies
Medical - Diagnostics & Research50 companies
Medical - Care Facilities46 companies
Medical - Healthcare Information Services41 companies
Medical - Pharmaceuticals21 companies
Drug Manufacturers - General20 companies
Medical - Healthcare Plans13 companies
Medical - Specialties11 companies
Medical - Distribution9 companies
Medical - Equipment & Services4 companies
Top Companies by Market Cap
Recent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | MAIA | MAIA Biotechnology, Inc. | Vitoc Vlad | director, 10 percent owner, officer: Chief Executive Officer | Buy | 73,000 | $1.37 | $100.0K |
| Sep 15, 2026 | PHVS | Pharvaris N.V. | Modig Berndt | director, officer: Chief Executive Officer | Sell | 2,291 | $39.40 | $90.3K |
| Sep 15, 2026 | CSTL | Castle Biosciences, Inc. | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | Sell | 14,518 | $32.02 | $464.9K |
| Sep 15, 2026 | AIM | AIM ImmunoTech Inc. | Equels Thomas K | director, officer: CEO & President | Buy | 5,900 | $0.22 | $1.3K |
| Sep 15, 2026 | UTHR | United Therapeutics Corporation | Mesa Nilda | director | Sell | 228 | $505.87 | $115.3K |
| Sep 15, 2026 | WST | West Pharmaceutical Services, Inc. | Favorite Annette F | officer: Sr. VP & Chief HR Officer | Sell | 7,524 | $355.03 | $2.67M |
| Sep 15, 2026 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | Sell | 9,943 | $98.37 | $978.1K |
| Sep 15, 2026 | COO | The Cooper Companies, Inc. | Kurzius Lawrence Erik | director | Buy | 10,000 | $53.92 | $539.1K |
| Sep 15, 2026 | HUMA | Humacyte, Inc. | Jones Keith Anthony | director | Buy | 10,000 | $0.56 | $5.6K |
| Sep 15, 2026 | IMNM | Immunome, Inc. | Higgins Jack | officer: Chief Scientific Officer | Sell | 13,200 | $25.32 | $334.2K |
| Sep 15, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $504.12 | $4.79M |
| Sep 15, 2026 | VREX | Varex Imaging Corporation | Kunkel Jay K. | director | Sell | 8,121 | $18.48 | $150.1K |
| Sep 15, 2026 | LQDA | Liquidia Corporation | SINGH RAMAN | director | Sell | 17,492 | $67.43 | $1.18M |
| Sep 15, 2026 | RVMD | Revolution Medicines, Inc. | Kelsey Stephen Michael | officer: See Remarks | Sell | 92,531 | $202.36 | $18.72M |
| Sep 15, 2026 | INBX | Inhibrx Biosciences Inc. | MANHARD KIMBERLY | director | Sell | 1,500 | $109.03 | $163.5K |
| Sep 15, 2026 | PACS | PACS Group, Inc. | Hancock Mark | director, 10 percent owner: | Sell | 300,000 | $43.48 | $13.04M |
| Sep 15, 2026 | CYTK | Cytokinetics, Incorporated | Blum Robert I | director, officer: President & CEO | Sell | 105,426 | $69.62 | $7.34M |
| Sep 15, 2026 | PHVS | Pharvaris N.V. | Lu Peng | officer: President | Sell | 15,000 | $40.13 | $601.9K |
| Sep 15, 2026 | KRRO | Korro Bio, Inc. | FORMELA JEAN FRANCOIS | director | Sell | 48,690 | $14.09 | $686.2K |
| Sep 15, 2026 | IPSC | Century Therapeutics, Inc. | Carr Douglas | officer: SVP Finance & Operations | Sell | 1,658 | $1.93 | $3.2K |
| Sep 15, 2026 | LFST | LifeStance Health Group, Inc. | TPG GP A, LLC | 10 percent owner | Sell | 18,409,705 | $12.29 | $226.25M |
| Sep 15, 2026 | COO | The Cooper Companies, Inc. | Rosebrough Walter M Jr | director | Buy | 10,000 | $54.16 | $541.6K |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Quinlan Paul T | officer: General Counsel | Sell | 1,039 | $95.71 | $99.4K |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Goncalves Joana | officer: Chief Medical Officer | Sell | 7,947 | $92.38 | $734.1K |
| Sep 15, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore Alan | officer: SVP, Chief Accounting Officer | Sell | 1,283 | $13.57 | $17.4K |
| Sep 15, 2026 | IRON | Disc Medicine, Inc. | Bitterman Kevin | director | Sell | 27,136 | $70.11 | $1.90M |
| Sep 15, 2026 | NBIX | Neurocrine Biosciences, Inc. | Boyer David W. | officer: Chief Corp. Affairs Officer | Sell | 826 | $157.45 | $130.1K |
| Sep 15, 2026 | HTFL | Heartflow, Inc. Common Stock | Verghese Vikram | officer: Chief Financial Officer | Sell | 34,975 | $50.08 | $1.75M |
| Sep 15, 2026 | CLOV | Clover Health Investments, Corp. | Reynoso Jamie L. | officer: CEO, Medicare Advantage | Sell | 9,273 | $4.78 | $44.3K |
| Sep 15, 2026 | CYTK | Cytokinetics, Incorporated | Landry Robert E | director | Sell | 1,000 | $72.13 | $72.1K |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Sandler Laura Lee | officer: Chief Operating Officer | Sell | 906 | $95.71 | $86.7K |
| Sep 15, 2026 | CARL | Carlsmed, Inc. | Presidio Management Group XII, L.L.C. | 10 percent owner | Buy | 200,000 | $15.00 | $3.00M |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Agarwal Arjun | officer: Senior Vice President, Finance | Sell | 10,019 | $92.43 | $926.0K |
| Sep 15, 2026 | ZBH | Zimmer Biomet Holdings, Inc. | Thornal Kevin R | officer: Grp Pres-Global Business | Sell | 5,691 | $92.95 | $529.0K |
| Sep 15, 2026 | BBNX | Beta Bionics, Inc. | Hopman Mark | officer: Chief Commercial Officer | Sell | 775 | $15.52 | $12.0K |
| Sep 15, 2026 | IPSC | Century Therapeutics, Inc. | Russotti Gregory | officer: See Remarks | Sell | 2,587 | $1.93 | $5.0K |
| Sep 15, 2026 | COO | The Cooper Companies, Inc. | Keel Paul A | director | Buy | 4,701 | $53.18 | $250.0K |
| Sep 15, 2026 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Ben Yong | director | Sell | 2,000 | $7.84 | $15.7K |
| Sep 15, 2026 | HNGE | Hinge Health, Inc. | Mecklenburg Gabriel M.I. | director, other: Exec. Chairman & Co-Founder | Sell | 150,000 | $93.22 | $13.98M |
| Sep 15, 2026 | CLOV | Clover Health Investments, Corp. | Soares Karen | officer: Chief Legal Officer | Sell | 6,846 | $4.78 | $32.7K |
| Sep 15, 2026 | VREX | Varex Imaging Corporation | Maheshwari Shubham | officer: Chief Financial Officer | Sell | 130,000 | $18.46 | $2.40M |
| Sep 15, 2026 | NBIX | Neurocrine Biosciences, Inc. | ABERNETHY MATT | officer: Chief Financial Officer | Sell | 2,311 | $157.20 | $363.3K |
| Sep 15, 2026 | ORKA | Oruka Therapeutics, Inc. | Klein Lawrence Otto | director, officer: Chief Executive Officer | Sell | 2,452 | $95.71 | $234.7K |
| Sep 15, 2026 | RCKT | Rocket Pharmaceuticals, Inc. | Wilson Martin | officer: General Counsel | Sell | 75,364 | $3.40 | $256.5K |
| Sep 14, 2026 | ANIX | Anixa Biosciences, Inc. | KUMAR AMIT | director, officer: Chief Executive Officer | Buy | 3,000 | $2.75 | $8.3K |
| Sep 14, 2026 | ANIX | Anixa Biosciences, Inc. | Titterton Lewis H jr | director | Buy | 10,000 | $2.73 | $27.3K |
| Sep 14, 2026 | MAIA | MAIA Biotechnology, Inc. | Guerrero Ramiro | director | Buy | 37,595 | $1.32 | $49.5K |
| Sep 14, 2026 | IRIX | IRIDEX Corporation | Dizon Romeo R | officer: Chief Financial Officer | Buy | 2,354 | $0.65 | $1.5K |
| Sep 14, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | officer: Chief Financial Officer | Sell | 10,810 | $32.36 | $349.8K |
| Sep 14, 2026 | TDOC | Teladoc Health, Inc. | DIVITA CHARLES III | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 17,805 | $6.10 | $108.7K |
Showing 1–50 of 500
1 / 10
...